Acquisition Talk

A daily blog on weapon systems acquisition

  • Home
  • Blog Posts
  • Podcast
  • PPBE Reform
  • About
  • Resources
    • Reading List
    • Links
    • Papers
    • Top Posts
    • AFWERX data
  • Contact

Amgen

Biotech business lessons for acquisition

May 23, 2019 Eric Lofgren 0

In the multibillion dollar biotech and pharmaceutical sectors, R&D is an integral requirement to be part of the industry. The FDA does not contract with […]

Share this:

  • Print
  • Facebook
  • LinkedIn
  • Reddit
  • Twitter

Get posts by email

Search

Featured

  • Acquisition headlines
  • DOD trusted capital marketplace
  • Why are OTAs plagued by references to FAR clauses?
  • USD R&E unveils a new Office of Strategic Capital
  • The cost, business model, and infrastructure of hypersonic vehicles
  • Defense Acquisition as a Cost Disease Sector: What’s the Evidence?
  • Acquisition headlines (2/14 – 2/20/2021)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

RSS Error: WP HTTP Error: A valid URL was not provided.

Copyright © 2025 | WordPress Theme by MH Themes